tradingkey.logo
tradingkey.logo
Suchen

Amneal Pharmaceuticals Inc

AMRX
Zur Watchlist hinzufügen
12.306USD
-0.084-0.68%
Trading geöffnet ETKurse um 15 Minuten verzögert
3.87BMarktkapitalisierung
31.74KGV TTM

Amneal Pharmaceuticals Inc

12.306
-0.084-0.68%

mehr Informationen über Amneal Pharmaceuticals Inc Unternehmen

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Amneal Pharmaceuticals Inc Informationen

BörsenkürzelAMRX
Name des UnternehmensAmneal Pharmaceuticals Inc
IPO-datumNov 18, 2009
CEOPatel (Chintu)
Anzahl der mitarbeiter8100
WertpapierartOrdinary Share
GeschäftsjahresendeNov 18
Addresse400 Crossing Boulevard, 3rd Floor
StadtBRIDGEWATER
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl08807
Telefon19089473120
Websitehttps://amneal.com/
BörsenkürzelAMRX
IPO-datumNov 18, 2009
CEOPatel (Chintu)

Führungskräfte von Amneal Pharmaceuticals Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Oral solid
726.38M
24.06%
Distribution
408.46M
13.53%
Central Nervous System
333.42M
11.04%
Government label
270.11M
8.95%
Other dosage forms
252.42M
8.36%
Andere
1.03B
34.05%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Oral solid
726.38M
24.06%
Distribution
408.46M
13.53%
Central Nervous System
333.42M
11.04%
Government label
270.11M
8.95%
Other dosage forms
252.42M
8.36%
Andere
1.03B
34.05%

Aktionärsstatistik

Aktualisiert: 17 hours ago
Aktualisiert: 17 hours ago
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
Patel (Dipan)
5.30%
Andere
57.73%
Aktionäre
Aktionäre
Anteil
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
Patel (Dipan)
5.30%
Andere
57.73%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
44.13%
Investment Advisor
19.79%
Investment Advisor/Hedge Fund
12.69%
Hedge Fund
11.08%
Private Equity
3.86%
Research Firm
2.61%
Pension Fund
0.72%
Bank and Trust
0.42%
Sovereign Wealth Fund
0.28%
Andere
4.42%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
521
161.64M
50.67%
-25.72M
2025Q4
448
154.72M
55.65%
+68.38K
2025Q3
455
154.66M
56.61%
+8.55M
2025Q2
432
145.89M
53.25%
+6.99M
2025Q1
416
138.78M
50.16%
-18.42M
2024Q4
398
129.01M
49.64%
-14.17M
2024Q3
380
143.02M
47.07%
+6.97M
2024Q2
372
135.82M
34.71%
+37.56M
2024Q1
356
97.40M
32.81%
-3.83M
2023Q4
348
89.35M
29.61%
+7.08M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Patel (Tushar Bhikhubhai)
48.58M
15.23%
-5.00M
-9.33%
Mar 14, 2025
Patel (Chintu)
26.14M
8.19%
+524.49K
+2.05%
Mar 12, 2026
Patel (Chirag K)
22.66M
7.1%
+535.49K
+2.42%
Mar 12, 2026
Akram (Mahesh)
20.56M
6.44%
-6.30M
-23.45%
Mar 31, 2025
Patel (Dipan)
16.90M
5.3%
-6.92M
-29.06%
Dec 31, 2025
Rubric Capital Management LP
12.33M
3.87%
--
--
Dec 31, 2025
TPG Capital, L.P.
12.33M
3.86%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
11.57M
3.63%
+231.50K
+2.04%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Invesco Pharmaceuticals ETF
3.08%
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2%
Invesco Dorsey Wright Healthcare Momentum ETF
0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
0.83%
First Trust NASDAQ Pharmaceuticals ETF
0.78%
First Trust Small Cap Growth AlphaDEX Fund
0.72%
iShares U.S. Pharmaceuticals ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.48%
WisdomTree US SmallCap Fund
0.36%
Mehr Anzeigen
Invesco Pharmaceuticals ETF
Anteil3.08%
State Street SPDR S&P Pharmaceuticals ETF
Anteil2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Anteil2%
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
Anteil0.83%
First Trust NASDAQ Pharmaceuticals ETF
Anteil0.78%
First Trust Small Cap Growth AlphaDEX Fund
Anteil0.72%
iShares U.S. Pharmaceuticals ETF
Anteil0.68%
ProShares Ultra Nasdaq Biotechnology
Anteil0.48%
WisdomTree US SmallCap Fund
Anteil0.36%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI